|
|
Article: Teva and Aventis Announce That COPAXONE Pre-Filled Syringe is Now Available Also in Europe.
- Article from:
- Business Wire
- Article date:
- June 17, 2004
CopyrightCOPYRIGHT 2004 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
JERUSALEM -- Combined with COPAXONE(R) sustained effect, the pre-filled syringe form significantly improves quality of life for patients with Multiple Sclerosis
Teva Pharmaceutical Industries Ltd. and Aventis Pharma today announced that the Multiple Sclerosis (MS) therapy COPAXONE(R) (glatiramer acetate injection) is now available also in Europe in a pre-filled, ready-to-use syringe (PFS). For physicians, nurses and pharmacists, compliance and adherence to treatment are among the most important factors in any therapy. With COPAXONE(R) PFS, injection will be faster and more convenient. No mixing or preparation is required, and fewer supplies are needed, ensuring ...